Literaturübersicht BEST-Studie

Leitlinien: 

Bschleipfer T, Schönburg S. S2e-Leitlinie Diagnostik und 

Therapie des Benignen Prostatasyndroms (BPS), Langversion 5.0, 2023. https://www.urologenportal.de/fachbesucher/wirueberuns/dgu/leitlinien-derdeutschen-gesellschaft-fuer-urologie.html2023 [21.12.23]. 

Gravas S., Cornu J.N., Gacci M., Gratzke C., Herrmann T.R.W., Mamoulakis C., et al. EAU Guidelines on Management of Non-Neurogenic Male LUTS Including Benign Prostatic Obstruction.: European Association of Urology; Arnhem, The Netherland: 2022; 2022. 

Wissenschaftliche Veröffentlichungen und Artikel: 

Abdelmoteleb, H., E. R. Jefferies and M. J. Drake (2016). "Assessment and management of male lower urinary tract symptoms (LUTS)." Int J Surg 25: 164-171. 

Acquadro, C., Z. Kopp, K. S. Coyne, J. Corcos, A. Tubaro, M. S. Choo and S. J. Oh (2006). "Translating overactive bladder questionnaires in 14 languages." Urology 67(3): 536-540. 

Akerla, J., J. S. Pesonen, A. Poyhonen, J. Koskimaki, J. Hakkinen, H. Huhtala, A. Auvinen and T. L. J. Tammela (2022). "Lower Urinary Tract Symptoms and Mortality among Finnish Men: The Roles of Symptom Severity and Bother." J Urol 207(6): 1285-1294. 

Albarqouni, L., S. Sanders, J. Clark, K. A. O. Tikkinen and P. Glasziou (2021). "Self-Management for Men With Lower Urinary Tract Symptoms: A Systematic Review and Meta-Analysis." Ann Fam Med 19(2): 157-167. 

Badia, X., M. Garcia-Losa and R. Dal-Ré (1997). "Ten-Language Translation and Harmonization of the International Prostate Symptom Score: Developing a Methodology for Multinational Clinical Trials." European Urology 31: 129-140. 

Barry, M. J., F. J. Fowler, Jr., M. P. O'Leary, R. C. Bruskewitz, H. L. Holtgrewe, W. K. Mebust and A. T. Cockett (1992). "The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association." J Urol 148(5): 1549-1557; discussion 1564. 

Barry, M. J., W. O. Williford, Y. Chang, M. Machi, K. M. Jones, E. Walker-Corkery and H. Lepor (1995). "Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?" J Urol 154(5): 1770-1774. 

Bent, A. E., A. E. Gousse, S. L. Hendrix, C. G. Klutke, A. K. Monga, C. K. Yuen, E. S. Meadows, I. Yalcin, D. Muram and G. Duloxetine Mixed Urinary Incontinence Study (2005). "Validation of a two-item quantitative questionnaire for the triage of women with urinary incontinence." Obstet Gynecol 106(4): 767-773. 

Berges, R. (2008). "[Epidemiology of benign prostatic syndrome. Associated risks and management data in German men over age 50]." Urologe A 47(2): 141-148. 

Blanker, M. H., H. J. Alma, T. S. Devji, M. Roelofs, M. G. Steffens and H. van der Worp (2019). "Determining the minimal important differences in the International Prostate Symptom Score and Overactive Bladder Questionnaire: results from an observational cohort study in Dutch primary care." BMJ Open 9(12): e032795. 

Boeri, L., P. Capogrosso, E. Ventimiglia, W. Cazzaniga, F. Pederzoli, D. Moretti, F. Deho, E. Montanari, F. Montorsi and A. Salonia (2017). "Clinically Meaningful Improvements in LUTS/BPH Severity in Men Treated with Silodosin Plus Hexanic Extract of Serenoa Repens or Silodosin Alone." Sci Rep 7(1): 15179. 

Bright, E., M. J. Drake and P. Abrams (2011). "Urinary diaries: evidence for the development and validation of diary content, format, and duration." Neurourol Urodyn 30(3): 348-352. 

Brown, C. T. and M. Emberton (2009). "Self-management for men with lower urinary tract symptoms." Curr Urol Rep 10(4): 261-266. 

Chapple, C. R., A. J. Wein, P. Abrams, R. R. Dmochowski, F. Giuliano, S. A. Kaplan, K. T. McVary and C. G. Roehrborn (2008). "Lower urinary tract symptoms revisited: a broader clinical perspective." Eur Urol 54(3): 563-569. 

Coyne, K., D. Revicki, T. Hunt, R. Corey, W. Stewart, J. Bentkover, H. Kurth and P. Abrams (2002). "Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q." Qual Life Res 11(6): 563-574. 

Coyne, K. S., M. K. Margolis, C. Thompson and Z. Kopp (2008). "Psychometric equivalence of the OAB-q in Danish, German, Polish, Swedish, and Turkish." Value Health 11(7): 1096-1101. 

Coyne, K. S., C. Payne, S. K. Bhattacharyya, D. A. Revicki, C. Thompson, R. Corey and T. L. Hunt (2004). "The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey." Value Health 7(4): 455-463. 

Djavan, B., M. Margreiter and S. S. Dianat (2011). "An algorithm for medical management in male lower urinary tract symptoms." Curr Opin Urol 21(1): 5-12. 

Dumoulin, C., J. Hay-Smith, G. M. Habee-Seguin and J. Mercier (2015). "Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women: a short version Cochrane systematic review with meta-analysis." Neurourol Urodyn 34(4): 300-308. 

Gacci, M., G. Corona, A. Sebastianelli, S. Serni, C. De Nunzio, M. Maggi, L. Vignozzi, G. Novara, K. T. McVary, S. A. Kaplan, S. Gravas and C. Chapple (2016). "Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis." Eur Urol 70(5): 788-796. 

Groenendijk, I. M., J. R. Scheepe, T. C. Noordhoff and B. F. M. Blok (2019). "The validation of the Dutch OAB-q SF: An overactive bladder symptom bother and health-related quality of life short-form questionnaire." Neurourol Urodyn 38(6): 1775-1782. 

Heßdörfer, E. (2016). "Mehr Augenmerk für LUTS." Uro-News 20(3): 10-10. 

Homma, Y., M. Gotoh, A. Kawauchi, Y. Kojima, N. Masumori, A. Nagai, T. Saitoh, H. Sakai, S. Takahashi, O. Ukimura, T. Yamanishi, O. Yokoyama, M. Yoshida and K. Maeda (2017). "Clinical guidelines for male lower urinary tract symptoms and benign prostatic hyperplasia." Int J Urol 24(10): 716-729. 

Hut, J., W. K. van der Heide, B. J. Kollen, E. J. Messelink, M. H. Blanker and J. H. Dekker (2017). "Pelvic floor muscle therapy or alpha-blocking agents for treatment of men with lower urinary tract symptoms: An exploratory randomized controlled trial." Int J Urol 24(6): 473-474. 

Laborde, E. E. and K. T. McVary (2009). "Medical management of lower urinary tract symptoms." Rev Urol 11(Suppl 1): S19-25. 

Miernik, A. and C. Gratzke (2020). "Current Treatment for Benign Prostatic Hyperplasia." Dtsch Arztebl Int 117(49): 843-854. 

Netto, N. R., Jr., M. L. de Lima, M. R. Netto and C. A. D'Ancona (1999). "Evaluation of patients with bladder outlet obstruction and mild international prostate symptom score followed up by watchful waiting." Urology 53(2): 314-316. 

Nichol, M. B., T. K. Knight, J. Wu, R. Barron and D. F. Penson (2009). "Evaluating use patterns of and adherence to medications for benign prostatic hyperplasia." J Urol 181(5): 2214-2221; discussion 2221-2212. 

Perchon, L. F., V. L. Pintarelli, E. Bezerra, M. Thiel and M. Dambros (2011). "Quality of life in elderly men with aging symptoms and lower urinary tract symptoms (LUTS)." Neurourol Urodyn 30(4): 515-519. 

Schmidt, F. and J. W. Thüroff (2019). Funktionsstörungen des unteren Harntraktes – Lower Urinary Tract Symptoms (LUTS) Thieme. 

Schulze, J. (2002). Aussagekraft des Internationalen Prostata Symptomen Score (IPSS) 

für Therapieplanung und 

Verlaufskontrolle bei der Benignen Prostatahyperplasie (BPH), Medizinischen Fakultät der 

Ludwig-Maximillians-Universität zu München. 

Van Asseldonk, B., J. Barkin and D. S. Elterman (2015). "Medical therapy for benign prostatic hyperplasia: a review." Can J Urol 22 Suppl 1: 7-17. 

Verhamme, K. M., J. P. Dieleman, G. S. Bleumink, J. L. Bosch, B. H. Stricker and M. C. Sturkenboom (2003). "Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: the Triumph project." Eur Urol 44(5): 539-545. 

Widdison, R., A. Rashidi and L. Whitehead (2022). "Effectiveness of mobile apps to improve urinary incontinence: a systematic review of randomised controlled trials." BMC Nurs 21(1): 32. 

Yap, T. L., C. Brown, D. A. Cromwell, J. van der Meulen and M. Emberton (2009). "The impact of self-management of lower urinary tract symptoms on frequency-volume chart measures." BJU Int 104(8): 1104-1108. 

Yuan, J. Q., C. Mao, S. Y. Wong, Z. Y. Yang, X. H. Fu, X. Y. Dai and J. L. Tang (2015). "Comparative Effectiveness and Safety of Monodrug Therapies for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Network Meta-analysis." Medicine (Baltimore) 94(27): e974.